Chiesi Belgium is part of the international Chiesi Group, a family-owned company with a strong focus on innovation and sustainability in healthcare. We develop and deliver high-quality medicines and solutions in the areas of respiratory diseases, neonatology, rare diseases, and special care. Our mission is clear: to improve healthcare and making a positive impact on the lives of patients worldwide. We are committed to building a sustainable future, with care for people, the environment, and society. Our activities are recognized as B CORP Certified, making us part of a global community of companies that use business as a force for good. Together with healthcare professionals and partners, we strive for a healthier world. Since 2022, we have joined forces with our colleagues in the Netherlands to form a proud Benelux organization. With around 100 passionate team members, we work every day to make an impact for patients, people, and the planet.
| Website | http://www.chiesi.be |
| Revenue | $3.3 billion |
| Employees | 36 (25 on RocketReach) |
| Founded | 2010 |
| Technologies |
Mailgun
,
Mimecast Mailbox Continuity
,
QlikView
+2 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pulmonary, Pharmaceutical, Rare Diseases, Respiratory, Therapeutics, Clinical Research, Drug Development, Clinical Trials, Healthcare, Inhalers, Medications, Pharma, Innovation, Biotechnology, Research, Prescription Drugs, Global Pharma, Drug Manufacturing, Health Solutions |
| Competitors | Takeda, Novartis, Roche, Pfizer, AstraZeneca, Boehringer Ingelheim, Sanofi, Merck Group, Lilly India, GSK +41 more (view full list) |
Looking for a particular Chiesi Belgium employee's phone or email?
The Chiesi Belgium annual revenue was $3.3 billion in 2026.
25 people are employed at Chiesi Belgium.